+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P01657(TMEM123 Antibody) at dilution 1/25. (Original magnification: ×200)    

  
  

The TMEM123 (Transmembrane Protein 123) antibody is a tool used to study the TMEM123 protein, a conserved transmembrane protein implicated in cellular processes such as membrane organization, vesicular trafficking, and autophagy. TMEM123. also known as PORMIN in some contexts, is expressed in various tissues, including the liver, kidney, and brain. Its structure features multiple transmembrane domains, suggesting roles in mediating protein-protein or membrane interactions. Research has linked TMEM123 to cancer progression, where its overexpression in certain tumors correlates with poor prognosis, potentially through regulating apoptosis or cell adhesion pathways. Additionally, studies suggest its involvement in neurological disorders, such as Alzheimer’s disease, though mechanisms remain under investigation.

TMEM123 antibodies are typically developed using immunogenic peptide regions of the protein and validated via techniques like Western blotting, immunohistochemistry, or immunofluorescence to ensure specificity. These antibodies enable researchers to analyze TMEM123's expression patterns, subcellular localization (e.g., plasma membrane, endoplasmic reticulum), and interactions in both normal and diseased states. Commercial TMEM123 antibodies are widely available, supporting basic and translational research. Their applications extend to biomarker discovery, therapeutic target validation, and mechanistic studies of TMEM123-related pathways. Proper validation remains critical due to potential cross-reactivity with structurally similar proteins.